This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1990 Apr;29(4):495-6.

doi: 10.1111/j.1365-2125.1990.tb03670.x.

Failure of a nomogram to achieve target aminoglycoside concentrations

PMID: 2328198
PMCID: PMC1380122
DOI: 10.1111/j.1365-2125.1990.tb03670.x

Comment

Failure of a nomogram to achieve target aminoglycoside concentrations

M W Perkins. Br J Clin Pharmacol. 1990 Apr.

. 1990 Apr;29(4):495-6.

doi: 10.1111/j.1365-2125.1990.tb03670.x.

Author

PMID: 2328198
PMCID: PMC1380122
DOI: 10.1111/j.1365-2125.1990.tb03670.x

No abstract available

PubMed Disclaimer

Comment on

Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations.
Begg EJ, Atkinson HC, Jeffery GM, Taylor NW. Begg EJ, et al. Br J Clin Pharmacol. 1989 Aug;28(2):137-41. doi: 10.1111/j.1365-2125.1989.tb05405.x. Br J Clin Pharmacol. 1989. PMID: 2775618 Free PMC article. Clinical Trial.

Similar articles

Validation of the Hartford nomogram in trauma surgery patients.
Finnell DL, Davis GA, Cropp CD, Ensom MH. Finnell DL, et al. Ann Pharmacother. 1998 Apr;32(4):417-21. doi: 10.1345/aph.17243. Ann Pharmacother. 1998. PMID: 9562135 Clinical Trial.
Value of the Australian antibiotic guidelines nomogram in monitoring aminoglycoside concentrations.
Buckley NA, Shakib S. Buckley NA, et al. Pathology. 1999 May;31(2):171-2. doi: 10.1080/003130299105403. Pathology. 1999. PMID: 10399177 No abstract available.
Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
Matthews I, Kirkpatrick C, Holford N. Matthews I, et al. Br J Clin Pharmacol. 2004 Jul;58(1):8-19. doi: 10.1111/j.1365-2125.2004.02114.x. Br J Clin Pharmacol. 2004. PMID: 15206987 Free PMC article.
Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility.
Zavascki AP, Klee BO, Bulitta JB. Zavascki AP, et al. Expert Rev Anti Infect Ther. 2017 Jun;15(6):519-526. doi: 10.1080/14787210.2017.1316193. Epub 2017 Apr 17. Expert Rev Anti Infect Ther. 2017. PMID: 28375030 Review.
Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics.
Horrevorts AM, Driessen OM, Michel MF, Kerrebijn KF. Horrevorts AM, et al. Chest. 1988 Aug;94(2 Suppl):120S-125S. Chest. 1988. PMID: 3293937 Review.

See all similar articles

Cited by

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.
Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R. Nicolau DP, et al. Antimicrob Agents Chemother. 1995 Mar;39(3):650-5. doi: 10.1128/AAC.39.3.650. Antimicrob Agents Chemother. 1995. PMID: 7793867 Free PMC article. Clinical Trial.
Aminoglycosides--50 years on.
Begg EJ, Barclay ML. Begg EJ, et al. Br J Clin Pharmacol. 1995 Jun;39(6):597-603. Br J Clin Pharmacol. 1995. PMID: 7654476 Free PMC article. Review.

References

1. Nephron. 1976;16(1):31-41 - PubMed
1. Antimicrob Agents Chemother. 1975 Jul;8(1):58-62 - PubMed
1. Br J Clin Pharmacol. 1989 Aug;28(2):137-41 - PubMed
1. Ann Intern Med. 1976 Aug;85(2):183-9 - PubMed
1. Eur J Clin Pharmacol. 1983;24(5):643-7 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information